The Cigna Group
CI
$309.83
$2.480.81%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | 65.37B | 63.61B | 60.20B | 56.97B | 50.82B |
Total Other Revenue | 277.00M | 85.00M | 321.00M | 290.00M | 290.00M |
Total Revenue | 65.65B | 63.69B | 60.52B | 57.26B | 51.11B |
Cost of Revenue | 59.19B | 57.09B | 54.01B | 50.87B | 44.54B |
Gross Profit | 6.46B | 6.60B | 6.52B | 6.38B | 6.57B |
SG&A Expenses | 3.74B | 3.52B | 3.63B | 3.68B | 3.75B |
Depreciation & Amortization | 424.00M | 436.00M | 420.00M | 423.00M | 451.00M |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 63.35B | 61.05B | 58.06B | 54.97B | 48.74B |
Operating Income | 2.30B | 2.64B | 2.47B | 2.29B | 2.37B |
Income Before Tax | 2.01B | 1.19B | 1.99B | 79.00M | 188.00M |
Income Tax Expenses | 473.00M | 367.00M | 360.00M | 291.00M | -919.00M |
Earnings from Continuing Operations | 1.54B | 825.00M | 1.63B | -212.00M | 1.11B |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -112.00M | -86.00M | -81.00M | -65.00M | -78.00M |
Net Income | 1.42B | 739.00M | 1.55B | -277.00M | 1.03B |
EBIT | 2.30B | 2.64B | 2.47B | 2.29B | 2.37B |
EBITDA | 2.94B | 3.29B | 3.21B | 3.03B | 3.14B |
EPS Basic | 5.13 | 2.65 | 5.51 | -0.97 | 3.49 |
Normalized Basic EPS | 3.89 | 4.80 | 4.38 | 4.07 | 3.93 |
EPS Diluted | 5.12 | 2.63 | 5.45 | -0.97 | 3.49 |
Normalized Diluted EPS | 3.89 | 4.75 | 4.34 | 4.07 | 3.93 |
Average Basic Shares Outstanding | 277.78M | 278.46M | 281.13M | 286.47M | 294.57M |
Average Diluted Shares Outstanding | 277.78M | 281.40M | 284.05M | 286.47M | 294.57M |
Dividend Per Share | 1.40 | 1.40 | 1.40 | 1.40 | 1.23 |
Payout Ratio | 26.97% | 52.77% | 25.32% | -144.77% | 34.79% |